A high expression of Cav-1 was observed in metastatic cancer, while a low expression of Cav-1 has been significantly related with overall survival in lung adenocarcinomas [25], thus proposing Cav-1 as a notable therapeutic target for cancer treatment. This evidence concerns the gene CAV1 and metastatic malignant neoplasm.